Schedule 13D ownership disclosure

Syndax Pharmaceuticals Inc

Security class unavailable · CUSIP: 87164F105

Event date: 2021-04-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-147745
Form type
SC 13D
Filer
Access Industries Holdings LLC
CIK
CIK 1391297
Filed
May 03, 2021
Reporting period
Apr 21, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub